Donna M. Hepper

Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway

Victor Huang, Donna M. Hepper, Milan J. Anadkat et al. · Archives of Dermatology · 2012 · 101 citations

Histopathology of acneiform eruptions in patients treated with epidermal growth factor receptor inhibitors

Lindsey A. Brodell, Donna M. Hepper, Anne C. Lind et al. · Journal of Cutaneous Pathology · 2013 · 38 citations

Histopathologic characteristics of therapy‐associated cutaneous neoplasms with vemurafenib, a selective <scp>BRAF</scp> kinase inhibitor, used in the treatment of melanoma

Kari E. Sufficool, Donna M. Hepper, Gerald P. Linette et al. · Journal of Cutaneous Pathology · 2014 · 14 citations · Full text

Nevoid hyperkeratosis of the areola misinterpreted as mycosis fungoides

Ilana S. Rosman, Donna M. Hepper, Anne C. Lind et al. · Journal of Cutaneous Pathology · 2012 · 10 citations